School of Pharmacy Publications

Browse Results (3962 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 47 of 80

Result Pages:    « first ‹ previous  37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Pulver, Lisa, Taylor, Donna, Tett, Susan E., Coombes, Judith and Petrie, Andrew (2008) Multicentre drug use evaluation in hospitals: Acute Postoperative Pain Management Project APOP Not available: 10  
Tett, Susan, Coombes, Judith and Pulver, Lisa (2011) Multicentre drug use evaluation in hospitals. QUM in hospitals: Queensland St. Lucia, QLD, Australia: The University of Queensland 19 3
Emmerton, Lynne M. and Benrimoj, S. I. (1994). Multidimensional scaling of non-prescription expectorants. In: Australasian Pharmaceutical Science Association Conference 1993, Brisbane, Australia, (). December 1993. 48  
Fujita, Y, Moyle, P. M., Olive, C., Good, M F and Toth, I (2006). Multi-epitopic lipid core peptide vaccine with broad protective immune responses against Group A streptococcus. In: 29th European Peptide Symposium. 29th European Peptide Symposium, Gdansk, (Abstract). 3-8 Sept, 2006. 56  
Marasini, Nirmal, Giddam, Ashwini K., Ghaffar, Khairunnisa A., Batzloff, Michael R., Good, Michael F., Skwarczynski, Mariusz and Toth, Istvan (2016) Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus. Nanomedicine, 11 10: 1223-1236. doi:10.2217/nnm.16.36     0 0 0
Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2016) Multinational evaluation of mycophenolic acid, tacrolimus, cyclosporin, sirolimus, and everolimus utilization. Annals of Transplantation, 21 1-11. doi:10.12659/AOT.895664     0 0 0
Emmerton, L. (2008) Multiple medicine purchases. Australian Pharmacist, 27 2: 181-182. 41  
Mountain, David C. and Cody, Alan R. (1999) Multiple modes of inner hair cell stimulation. Hearing Research, 132 1-2: 1-14. doi:10.1016/S0378-5955(99)00013-1 51   37 Cited 32 times in Scopus32 0
Barraclough, K. A., Isbel, N. M., Franklin, M. E., Lee, K. J., Taylor, P.J., Campbell, S. B., Petchey, W.G. and Staatz, C. E. (2010). Multiple regression derived limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in Australian adult kidney transplant recipients. In: Proceedings : XXIII International Congress of the Transplant Society. XXIII International Congress of the Transplant Society, Vancouver, Canada, (). 15-19 August 2010. 47  
Hollingworth, Samantha, Walker, Kimitra, Page, Andrew and Eadie, Mervyn (2014) Multiple sclerosis disease modifying medicine utilisation in Australia. Journal of Clinical Neuroscience, 21 12: 2083-2087. doi:10.1016/j.jocn.2014.05.034 23   0 0 1
Khan, Nemat and Smith, Maree T. (2013) Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology, 22 1: 1-22. doi:10.1007/s10787-013-0195-3 84   7 Cited 11 times in Scopus11 1
Nissen, Lisa (2007) Multiple sclerosis - Where are we now?. Australian Pharmacist, 26 10: 780-785. 52  
Kruger, W. A., Monteith, G R and Poronnik, P (2006). Muscarinic agonist-induced recruitment of PMCA to themembrance involves the PDZ scaffold NA+ H+ exchanger regulatory factor 2 (NHERF-2). In: Combined Conference Abstracts: ComBio 2006. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, (108-108). 24-28 September, 2006. 46  
Kruger, Wade A., Yan, C. Chris, Monteith, Gregory R. and Poronnik, Philip (2009) Muscarinic-induced recruitment of plasma membrane Ca2+-ATPase involves PSD-95/Dlg/Zo-1-mediated interactions. Journal of Biological Chemistry, 284 3: 1820-1830. doi:10.1074/jbc.M804590200 73   14 Cited 13 times in Scopus13 0
Ding, W. J., Munns, A. and Cottrell, W. N. (2007). Musculoskeletal pain and preferences when choosing an analgesic in patients with heart failure. In: Annual Conference of the Australasian Pharmaceutical Science Association, Sydney, Australia, (). 8-11 December 2007. 37  
Marinaki, AM, Duley, JA, Arenas, M, Ansari, A, Sumi, S, Lewis, CM, Shobowale-Bakre, M, Fairbanks, LD and Sanderson, J (2004) Mutation in the ITPA gene predicts intolerance to azathioprine. Nucleosides Nucleotides & Nucleic Acids, 23 8-9: 1393-1397. doi:10.1081/NCN-200027639 100   34 Cited 41 times in Scopus41 3
Bryan-Lluka, L. J. and Paczkowski, F. A. (2000). Mutations in transmembrane domain (TMD) 5 of the human noradrenaline transporter (hNAT) cause increases in substrate affinities but decreases in inhibitor affinities. In: W.C. Hodgson and R. E. Loiacono, Proceedings of ASCEPT. Joint Meeting of ASCEPT and the British Pharmacological Society, Newcastle, Australia, (67-67). 3 - 6 December, 2000. 36  
Gujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009) Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 3: 202-206. 143   0
Mori, Silvia, Bernardi, Rosa, Laurent, Audrey, Resnati, Massimo, Crippa, Ambra, Gabrieli, Arianna, Keough, Rebecca, Gonda, Thomas J. and Blasi, Francesco (2012) Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressor. PLoS One, 7 10: e39723.1-e39723.14. doi:10.1371/journal.pone.0039723 55   7 Cited 9 times in Scopus9 23
Hochstatter, Julia, Hölzel, Michael, Rohrmoser, Michaela, Schermelleh, Lothar, Leonhardt, Heinrich, Keough, Rebecca, Gonda, Thomas J., Imhof, Axel, Eick, Dirk, Längst, Gernot and Németh, Attila (2012) Myb-binding Protein 1a (Mybbp1a) Regulates Levels and Processing of Pre-ribosomal RNA. Journal of Biological Chemistry, 287 29: 24365-24377. doi:10.1074/jbc.M111.303719 35   8 Cited 9 times in Scopus9 0
Ye, Ping, Zhao, Liang, McGirr, Crystal and Gonda, Thomas J. (2014) MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo. Cancer Letters, 343 1: 98-106. doi:10.1016/j.canlet.2013.09.022 72   5 Cited 4 times in Scopus4 0
Pereira, Lloyd A., Hugo, Honor J., Malaterre, Jordane, Huiling, Xu, Sonza, Secondo, Cures, Alina, Purcell, Damian F. J., Ramsland, Paul A., Gerondakis, Steven, Gonda, Thomas J. and Ramsay, Robert G. (2015) MYB elongation is regulated by the nucleic acid binding of NFκB p50 to the intronic stem-loop region. PLoS One, 10 4: 1-25. doi:10.1371/journal.pone.0122919 25   1 Cited 1 times in Scopus1 1
Tett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011) Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 2: 47-57. doi:10.1016/j.trre.2010.06.001 59   35 Cited 42 times in Scopus42 0
Chocair, Pedro R. and Duley, John A. (2012) Mycophenolate has replaced azathioprine in immunosuppression regimens. But is it better?. Revista da Associação Médica Brasileira, 58 Supp. 1: S24-S27. 116 9
Chocair, Pedro R. and Duley, John A. (2012) Mycophenolate or azathioprine maintenance in lupus nephritis. New England Journal of Medicine, 366 6: 572-572. doi:10.1056/NEJMc1114605 34 1 0 0 4
Staatz, Christine, Wong, Jenny, Taylor, Paul, Johnson, David and Tett, Susan (2007). Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period. In: Therapeutic drug monitoring: Abstracts of the 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, (539-539). 9-14 September, 2007. doi:10.1097/FTD.0b013e31813797e8 138   0 0 1
Atcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I. and Tett, Susan E. (2005) Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. British Journal of Clinical Pharmacology, 59 3: 271-280. doi:10.1111/j.1365-2125.2004.02235.x 111   55 Cited 67 times in Scopus67 0
Green, B, Duffull, S, Cottrell, N and D'Emden, M (2002) Myocardial infarction and type II diabetes - preferential treatment for high risk patients?. Journal of Clinical Pharmacy And Therapeutics, 27 5: 371-376. doi:10.1046/j.1365-2710.2002.00436.x 69   0 Cited 2 times in Scopus2 0
Ross, Benjamin P., Falconer, Robert A. and Toth,, Istvan (2008) N-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (N-Dde) Lipoamino Acids. Molbank, 2008: M566 2: . doi:10.3390/M566 60   0
Nissen, Lisa (2011) Naloxone - helping treat tricky bowels?. Australian Pharmacist, 30 10: 832-832. 24 2
Nissen, Lisa (2008) Naltrexone - from drug dependence to irritable bowel?. Australian Pharmacist, 27 2: 133-134. 69  
Zhang, Jun, Raphael, Anthony P., Yang, Yannan, Popat, Amirali, Prow, Tarl W. and Yu, Chengzhong (2014) Nanodispersed UV blockers in skin-friendly silica vesicles with superior UV-attenuating efficiency. Journal of Materials Chemistry B, 2 44: 7673-7678. doi:10.1039/c4tb01332h 63   2 Cited 2 times in Scopus2 0
Deng, Zhou J., Liang, Mingtao, Monteiro, Michael, Toth, Istvan and Minchin, Rodney F. (2011) Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology, 6 1: 39-44. doi:10.1038/NNANO.2010.250 138   276 Cited 303 times in Scopus303 0
Wan, Yu, Moyle, Peter M., Christie, Michelle P. and Toth, Istvan (2016) Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity. Nanomedicine, 11 8: 907-919. doi:10.2217/nnm.16.27     0 0 0
Dutta, Tathagata, Garg, Minakshi, Jain, Narendra K. and Adeli, Mohsen (2009). Nanotechnological application of novel polymers. In Mohsen Adeli (Ed.), Nanotechnological application of novel polymers (pp. 1-14) Kerala, India: Research Signpost. 141  
Teli, Mahesh Kumar, Mutalik, Srinivas and Rajanikant, G. K. (2010) Nanotechnology and nanomedicine: Going small means aiming big. Current Pharmaceutical Design, 16 16: 1882-1892. doi:10.2174/138161210791208992 118 2 26 Cited 29 times in Scopus29 0
Zaman, Mehfuz, Good, Michael F. and Toth, Istvan (2013) Nanovaccines and their mode of action. Methods, 60 3: 226-231. doi:10.1016/j.ymeth.2013.04.014 36   15 Cited 18 times in Scopus18 0
Yow, Tin T., Pera, Elena, Absalom, Nathan, Heblinski, Marika, Johnston, Graham A. R., Hanrahan, Jane R. and Chebib, Mary (2011) Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. British Journal of Pharmacology, 163 5: 1017-1033. doi:10.1111/j.1476-5381.2011.01315.x 51   22 Cited 23 times in Scopus23 0
Illum, L., Davis, S.S., Pawula, M., Fisher, A.N., Barrett, D.A., Farraj, N.F. and Shaw, P.N. (1996) Nasal administration of morphine-6-glucuronide in sheep - A pharmacokinetic study. Biopharmaceutics and Drug Disposition, 17 8: 717-724. doi:10.1002/(SICI)1099-081X(199611)17:8<717::AID-BDD985>3.0.CO;2-I 32   18 Cited 19 times in Scopus19 0
Yoongthong, Worasuda, Hu, Shanlian, Whitty, Jennifer A., Wibulpolprasert, Suwit, Sukantho, Kitti, Thienthawee, Wannisa, Han, Huixue and Scuffham, Paul A. (2012) National drug policies to local formulary decisions in Thailand, China, and Australia: drug listing changes and opportunities. Value in Health, 15 1 Supp. 1: S126-S131. doi:10.1016/j.jval.2011.11.003 30   7 Cited 11 times in Scopus11 0
Overland, V., Roughead, E. E. and Tett, S. E. (2000). National medicines policy evaluation using qummap.health.gov.au. In: M. Smith, R. Prankerd and S. Duffull, Proceedings of APSA 2000. APSA 2000 Annual Conference, Newcastle, (57). 6-8 Dec. 2000. 46  
Hollingworth, Samantha, Duhig, Michael, Hall, Wayne and Scott, James (2013) National trends in the community prescribing of second-generation antipsychotic medications in Australian children and youth: the incomplete story. Australasian Psychiatry, 21 5: 442-445. doi:10.1177/1039856213497809 71 58 6 Cited 7 times in Scopus7 2
Rahman, Shafiur, Cao, Siyu, Steadman, Kathryn J., Wei, Ming and Parekh, Harendra S. (2012) Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer. Drug Delivery, 19 7: 346-353. doi:10.3109/10717544.2012.721143 131   19 Cited 27 times in Scopus27 0
Dean, Angela J. (2005) Natural and complementary therapies for substance use. Current Opinion in Psychiatry, 18 3: 271-276. doi:10.1097/01.yco.0000165597.06176.71 38   6 0 7
Vetter, Irina and Lewis, Richard J. (2011). Natural product ligands of TRP channels. In Md. Shahidul Islam (Ed.), Transient receptor potential channels (pp. 41-85) New York, United States: Springer. doi:10.1007/978-94-007-0265-3_3 83 3 8 Cited 8 times in Scopus8 1
Burrows, J. A., Bunting, J. P., Masel, P. J. and Bell, S. C. (2002) Nebulised dornase alpha: adherence in adults with cystic fibrosis. Journal of Cystic Fibrosis, 1 4: 255-259. doi:10.1016/S1569-1993(02)00095-4 74   Cited 23 times in Scopus23 0
Gow, Paul J., Ghabrial, Hany, Smallwood, Richard A., Morgan, Denis J. and Ching, Michael S. (2001) Neonatal hepatic drug elimination. Pharmacology & Toxicology, 88 1: 3-15. doi:10.1034/j.1600-0773.2001.088001003.x 46   41 0 3
Chen, Qian, Wang, Haitao, Liao, Sufen, Gao, Yang, Liao, Rifang, Little, Peter J., Xu, Jiangping, Feng, Zhong-Ping, Zheng, Yongxin and Zheng, Wenhua (2015) Nerve growth factor protects retinal ganglion cells against injury induced by retinal ischemia-reperfusion in rats. Growth Factors, 33 2: 149-159. doi:10.3109/08977194.2015.1010642 18   1 Cited 1 times in Scopus1 0
Smith, M., Vicenzino, G. T. and Emmerton, L. M. (2007) Netball knee. Australian Pharmacist, 26 6: 462-464. 132  
Smith, M. T. (2003). Neurobiology of Pain: Identification of novel targets for new pain management medications. In G. Keri and I. Toth (Ed.), Molecular Pathomechanisms and New Trends in Drug Research 1 ed. (pp. 302-318) London & New York: Taylor & Francis. 150  

Page 47 of 80

Result Pages:    « first ‹ previous  37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56  next › last »